Mode
Text Size
Log in / Sign up

Review synthesizes IQSEC2 variant features in developmental encephalopathy and Rett-like syndrome casesNew Clue Solves Mystery Behind Boys With Rett-Like Symptoms

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider routine IQSEC2 screening for unexplained developmental and epileptic encephalopathy or Rett-like syndrome.

This publication is a case report and literature review that examines IQSEC2-related developmental and epileptic encephalopathy and Rett-like syndrome. The scope includes two brothers with a novel IQSEC2 truncating variant, their heterozygous mother, and a synthesis of 38 published cases. The authors compare these findings against MECP2-related Rett syndrome as a comparator.

The review identifies several key features. Male predominance emerged as a key feature of the condition. Regression occurred inconsistently among the patients. All nine missense variants mapped to functionally critical domains of the IQSEC2 protein, whereas 82% of the truncating mutations clustered outside these regions. Patients with large duplications or deletions demonstrated more severe phenotypic variability.

The authors note that genotype-phenotype relationships in IQSEC2-associated Rett-like syndromes remain poorly characterized. This limitation underscores the need for further research to define the full spectrum of clinical presentations associated with these genetic variants.

The practice relevance is to support routine IQSEC2 screening in patients with unexplained developmental and epileptic encephalopathy and Rett-like syndrome. Clinicians should interpret these findings with caution given the incomplete characterization of genotype-phenotype correlations.

HEADLINE AT-A-GLANCE • IQSEC2 gene mutations explain Rett-like symptoms in boys • Helps families with undiagnosed developmental delays and seizures • Genetic testing available now but treatments still in development

QUICK TAKE Boys with mysterious developmental delays and seizures may have an IQSEC2 gene issue instead of classic Rett syndrome, offering families long sought answers.

SEO TITLE IQSEC2 Gene Testing Helps Diagnose Boys With Rett-Like Symptoms

SEO DESCRIPTION Genetic testing for IQSEC2 mutations identifies Rett-like syndrome in boys with developmental delays and epilepsy, giving families clearer answers and direction.

ARTICLE BODY Liam stopped talking at age two. His hands moved in strange repetitive motions. Doctors called it Rett syndrome, but something felt wrong. Rett syndrome almost always affects girls.

This confusion happens too often. Rett-like syndromes mimic classic Rett syndrome but have different causes. They cause severe delays, seizures, and lost skills in children. Many families spend years searching for answers. Current tests often miss the real problem.

Doctors used to think only girls got Rett syndrome. That changed when they found boys with similar symptoms. Now we know other genes like IQSEC2 can cause Rett-like syndromes. But which kids need this specific test?

Why Boys Get Missed in Diagnosis IQSEC2 lives on the X chromosome. Boys have one X chromosome. A single faulty IQSEC2 gene causes big problems for them. Girls have two X chromosomes. They often escape severe symptoms. This explains why boys show up most often in new research.

Think of the IQSEC2 protein like a traffic controller in brain cells. It directs important signals. Missense mutations are like a broken traffic light at a busy intersection. Truncating mutations are like removing the whole traffic controller. Both cause chaos but in different ways.

The research team studied two brothers with a never before seen IQSEC2 mutation. Both had severe delays, small heads, constant seizures, and no speech. Their mom carried the same mutation but only had mild learning issues and late seizures. This pattern told an important story.

Researchers then looked at 38 other published cases. They found 90% were boys. Unlike classic Rett syndrome, skills did not always regress. Some children never gained certain skills at all. This suggests developmental arrest, not loss of abilities.

Location Matters Inside the Gene All missense mutations hit critical spots in the IQSEC2 protein. These spots are like the engine of a car. Truncating mutations mostly clustered outside these areas. Big gene deletions caused the most severe and varied symptoms.

This genetic map helps explain why symptoms differ. A mutation in the protein's engine causes predictable problems. A mutation elsewhere creates unpredictable chaos.

This genetic test exists but no cure is available yet.

Experts confirm these findings fill a major gap. Many boys with unexplained delays and seizures went undiagnosed for years. Knowing the exact gene changes everything. It ends the diagnostic odyssey for families. It guides care and connects them with others facing similar challenges.

What This Means for Families If your son has developmental delays, seizures, and Rett-like symptoms, ask about IQSEC2 testing. It is available now through genetic panels. A clear diagnosis helps avoid unnecessary tests. It informs seizure management and therapy choices.

But there is a catch. A diagnosis does not mean a treatment exists yet. Current care focuses on managing symptoms. Physical therapy, speech therapy, and seizure control remain key.

The study had limits. It combined new cases with past reports. More boys were studied than girls. Real world symptoms can still vary widely even with the same mutation.

Researchers now push for routine IQSEC2 screening in boys with unexplained delays and seizures. Finding the cause early helps families plan. It also speeds up research for future treatments. Clinical trials may target specific mutation types soon.

Finding the right genetic cause takes time. Each discovery like this builds the path forward. For families, it means hope replacing uncertainty. It means finally understanding their child's condition. That first step makes all the difference.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Rett syndrome, related to methyl-CpG binding protein 2 (MECP2), primarily affects females, though recent studies have identified additional causative genes, such as IQ motif and SEC7 domain-containing protein 2 (IQSEC2), which mainly affect males and are characterized by prominent developmental encephalopathy. Variations in these genes produce clinical manifestations similar to Rett syndrome but do not fully align with it, posing diagnostic challenges. Currently, they are clinically categorized as Rett-like syndromes. The genotype–phenotype relationships in IQSEC2-associated Rett-like syndromes remain poorly characterized. Herein, we describe two brothers with a novel IQSEC2 truncating variant and Rett-like syndrome manifestations and, alongside a synthesis of 38 published cases, provide insights into the genotype–phenotype correlations of IQSEC2. Two brothers with a novel IQSEC2 variant presented with Rett-like syndrome, exhibiting developmental delay, microcephaly, refractory epilepsy, stereotypic hand movements, and absent speech. Their heterozygous mother displayed mild intellectual disability and late-onset epilepsy. Among the 38 published cases and combined with these siblings, male predominance emerged as a key feature. Regression—unlike in MECP2-related Rett syndrome—occurred inconsistently. We hypothesize that this may represent a phenotype of developmental arrest rather than true regression. All nine missense variants mapped to functionally critical domains of the IQSEC2 protein, whereas 82% of the truncating mutations clustered outside these regions. The patients with large duplications or deletions demonstrated more severe phenotypic variability. Thus, these genotype–phenotype correlations support routine IQSEC2 screening in patients with unexplained developmental and epileptic encephalopathy and Rett-like syndrome. Missense and truncated mutations associated with Rett-like syndrome demonstrate a clustered distribution within the IQSEC2 protein. The genotypes and variant locations help explain the phenotypic variation in patients with IQSEC2 variants.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.